Vistin Pharma ASAVistin Pharma ASAVistin Pharma ASA

Vistin Pharma ASA

No trades
See on Supercharts
Market capitalization
‪1.08 B‬NOK
‪62.75 M‬NOK
‪429.09 M‬NOK
‪20.98 M‬
Beta (1Y)
0.14
Employees (FY)
75
Change (1Y)
−2 −2.60%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About VISTIN PHARMA ASA


CEO
Magnus Tolleshaug
Website
Headquarters
Oslo
Founded
2015
ISIN
NO0010734122
FIGI
BBG01L8XS7G8
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.

Check out other big names from the same industry as VISTNO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on AQUISEU exchange Vistin Pharma ASA stocks are traded under the ticker VISTNO.
VISTNO reached its all-time high on Oct 1, 2024 with the price of 50 NOK, and its all-time low was 0 NOK and was reached on Jan 17, 2025. View more price dynamics on VISTNO chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Vistin Pharma ASA financials in yearly and quarterly reports right on TradingView.
VISTNO net income for the last quarter is ‪21.70 M‬ NOK, while the quarter before that showed ‪19.37 M‬ NOK of net income which accounts for 12.01% change. Track more Vistin Pharma ASA financial stats to get the full picture.
Vistin Pharma ASA dividend yield was 5.27% in 2024, and payout ratio reached 88.34%. The year before the numbers were 4.29% and 97.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2025, the company has 75 employees. See our rating of the largest employees — is Vistin Pharma ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vistin Pharma ASA EBITDA is ‪114.10 M‬ NOK, and current EBITDA margin is 24.22%. See more stats in Vistin Pharma ASA financial statements.
Like other stocks, VISTNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vistin Pharma ASA stock right from TradingView charts — choose your broker and connect to your account.